The full process guide for IVF in the United States: from examination to transplantation, just read this article

For many families facing fertility challenges, IVF technology in the United States represents a combination of hope and science. As a global leader in the field of assisted reproduction, the United States has a comprehensive healthcare system, advanced laboratory technology, and strict medical regulatory standards. This article will comprehensively analyze the complete process from preliminary examination to embryo transfer, helping you systematically understand every step of assisted reproductive treatment in the United States.

1、 Preliminary preparation and medical evaluation

A comprehensive medical evaluation is the foundation for ensuring success rate before officially initiating the treatment cycle. It is usually recommended that both spouses start preparing three months before planning treatment, which includes lifestyle adjustments and optimization of basic health conditions. Reproductive centers in the United States typically require patients to complete a series of standardized tests before their first visit, in order for doctors to develop precise treatment plans.

1.1 Basic examination items for women

Women need to complete a series of reproductive system assessments, including:

• Six hormone testsEvaluate the levels of FSH (follicle stimulating hormone), LH (luteinizing hormone), E2 (estradiol), PRL (prolactin), T (testosterone), and P (progesterone) on the 2nd to 4th day of the menstrual cycle to reflect ovarian reserve function
• AMH testingAnti Mullerian hormone testing, not affected by menstrual cycle, is the gold standard for evaluating egg reserve, and the normal range varies by age
• Basic follicle count (AFC)Check the number of basal antral follicles through transvaginal ultrasound, usually on the 2nd to 4th day of the menstrual cycle
• hysterosalpingographyEvaluate the morphology of the uterine cavity and the patency of the fallopian tubes, and exclude lesions such as uterine fibroids, polyps, or adhesions
• Infectious disease screening: Including HIV, hepatitis B, hepatitis C, syphilis, etc., which is the standard requirement of the US FDA for assisted reproductive treatment
• Thyroid function and coagulation functionExcluding endocrine and coagulation abnormalities, thyroid dysfunction may significantly affect pregnancy outcomes
• hysteroscopyFor suspected uterine abnormalities, it is recommended to undergo diagnostic hysteroscopy examination

1.2 Basic examination items for males

• Semen analysisIncluding sperm concentration, vitality, and morphological evaluation, it is recommended to check after 2-7 days of abstinence and repeat 2-3 times if necessary
• Sperm DNA Fragmentation Index (DFI)Assessing the integrity of sperm genetic material, high DFI may lead to fertilization failure or early miscarriage
• Reproductive hormone testingEvaluate testicular function and hypothalamic pituitary gonadal axis function, including FSH, LH, testosterone, etc
• Infectious disease screeningSame standards as women to ensure biological safety
• Ultrasound of the urinary and reproductive systemExclude organic lesions such as varicocele

1.3 Genetic screening and counseling

For couples with a history of genetic disease or advanced age, it is recommended to undergo Extended Carrier Screening (ECS), which can detect the carrier status of hundreds of recessive genetic diseases. In addition, chromosome karyotyping analysis can exclude structural abnormalities such as balanced translocations. American clinics usually have professional genetic counselors to help patients understand test results and their impact on future generations.

2、 Develop personalized ovulation induction plan

Based on the preliminary assessment results, reproductive experts will develop personalized ovarian stimulation plans. American clinics typically use antagonist regimens, rectangular regimens, or micro stimulation regimens, based on factors such as age, AMH values, baseline FSH levels, body mass index, and past treatment history.

2.1 Comparison of Common Drainage Promotion Plans

Solution Type	For the crowd	treatment cycle	Main Features
Antagonist regimen	Individuals with normal or high ovarian response	10-12 days	Short cycle, flexible medication, low risk of ovarian hyperstimulation syndrome (OHSS), can trigger ovulation at any time
Rectangular Plan (Lower Adjustment)	Endometriosis or requiring time coordinator	4-6 weeks	Good synchronization of follicles, stable number of retrieved eggs, and inhibition of endogenous hormone interference through pituitary down-regulation
Micro stimulation plan	Low ovarian reserve or elderly women	8-10 days	Low drug dosage, light burden on the body, utilizing its own FSH peak to promote follicle growth
natural cycle	Refusing medication stimulation or those with poor ovarian function	Following the menstrual cycle	No drug stimulation, low number of retrieved eggs (usually 1), closest to physiological state
Luteal phase promotes excretion	Ovarian hyporesponders	continuous cycle	Stimulate again during the luteal phase, obtaining two opportunities for egg retrieval in one menstrual cycle

2.2 Use and monitoring of ovulation inducing drugs

Common medications include FSH drugs such as Gonal-F, Menopur, Bravelle, as well as GnRH antagonists such as Cetrotide or Ganirelix. Close monitoring is required during medication:

• Perform vaginal ultrasound monitoring of follicle growth every 2-3 days, measuring follicle diameter and endometrial thickness
• Regularly monitor serum levels of E2, LH, and P, and adjust medication dosage based on hormone levels
• When the dominant follicle reaches 18-20mm and most follicles reach 16-17mm with appropriate E2 levels, injection of HCG (human chorionic gonadotropin) or GnRH agonist (such as leuprorelin) triggers ovulation
• Arrange egg retrieval surgery 34-36 hours after triggering

Important reminder: The US FDA strictly regulates the use of ovulation inducing drugs, and all medication must be taken under the guidance of a practicing doctor. It is strictly prohibited to adjust the dosage on your own.

3、 Egg retrieval and in vitro fertilization techniques

3.1 Procedure for Egg Retrieval Surgery

Egg retrieval surgery should be performed 34-36 hours after triggering. In the United States, transvaginal ultrasound-guided egg retrieval is performed under intravenous anesthesia (Propofol or Midazolam combined with Fentanyl), and the entire process takes about 15-30 minutes. Patients have no painful memories. The surgery uses a 16-17G oocyte retrieval needle to puncture ovarian follicles under ultrasound guidance, and negative pressure suction is used to obtain follicular fluid.

After 2-3 hours of postoperative observation, if there is no bleeding or severe discomfort, you can leave the hospital. Common postoperative reactions include mild abdominal pain, bloating, and slight vaginal bleeding, which usually subside within 24-48 hours. Laboratory personnel immediately searched for eggs under a microscope and evaluated the maturity of the corona cumulus complex (OCCC)

• Mature egg (MII stage): capable of fertilization, with visible first polar body
• Immature eggs (MI or GV stage): can be cultured and matured in vitro (IVM technique)
• Abnormal egg: such as empty follicles or abnormal morphology

3.2 Sperm Processing and Fertilization Method Selection

On the day of egg retrieval, males collect semen samples through masturbation (if there is a history of surgical sperm retrieval, microscopic sperm retrieval should be arranged in advance). The laboratory processes semen using density gradient centrifugation or upstream method (Swim up) to enrich highly motile sperm.

Choose fertilization method based on sperm quality:

• Conventional IVFCo culture eggs with processed sperm, typically at a sperm concentration of 50000-100000 per egg, suitable for individuals with normal sperm quality and no history of fertilization disorders
• ICSI (intracytoplasmic sperm injection)Laboratory technicians select individual sperm with normal morphology and good vitality under an inverted microscope, and directly inject them into the cytoplasm of the egg using a microinjection needle. Suitable for severe oligozoospermia, previous fertilization failure, thick zona pellucida of eggs, or those undergoing PGT testing
• IMSI (Sperm Selection under High Power Microscopy)Using a microscope with a magnification of over 6000 times to observe sperm morphology and selecting sperm without morphological abnormalities for ICSI may improve fertilization rates

3.3 Embryo Culture and Evaluation System

Top laboratories in the United States use Time lapse photography incubators (such as EmbryoScope or GERI) to continuously monitor embryo development without interfering with the culture environment. The incubator is equipped with a microscope and camera, which take a photo every 5-15 minutes to generate a lap video of embryo development time.

Standard culture until day 5-6 forms blastocysts, at which point the number of embryonic cells reaches over 100, differentiating into inner cell mass (ICM, which will develop into a fetus) and trophoblast layer (TE, which will develop into a placenta). The grading of blastocysts is based on the Gardner system, which evaluates the degree of expansion of the blastocyst cavity, the quality of the inner cell mass and trophoblast cells (such as 4AA, 5AB, etc.).

4、 Pre implantation genetic testing (PGT)

This is one of the core advantages of IVF technology in the United States. Obtaining 5-10 cells through trophoblast biopsy for genetic analysis, the main techniques include:

• PGT-A (non diploid screening)Screening for abnormal chromosome numbers in embryos (such as trisomy 21 and trisomy 18) can improve implantation rates and reduce miscarriage rates, especially suitable for elderly (≥ 35 years old) or recurrent miscarriage patients
• PGT-M (Single Gene Disease Detection)Testing for monogenic genetic diseases such as thalassemia, cystic fibrosis, and spinal muscular atrophy, suitable for couples known to carry pathogenic genes
• PGT-SR (Structural Rearrangement Detection)Detection of chromosomal structural abnormalities (such as balanced translocation and Roche translocation) to reduce the risk of miscarriage caused by imbalanced gamete formation

After testing, the embryos need to be stored using vitrification technology, waiting for the test results (usually 7-14 days) and preparation for subsequent transplantation cycles. The freezing recovery rate in American laboratories usually exceeds 95%, and the pregnancy rate of frozen embryos is comparable to that of fresh embryos.

5、 Endometrial preparation and embryo transfer

5.1 Endometrial preparation plan for transplantation cycle

The United States mainly adopts the frozen embryo transfer (FET) strategy, with two main endometrial preparation schemes:

plan	Applicable scenarios	operating procedure	Monitoring points
Human Cycle Time (HRT)	Irregular menstruation, ovulation disorders, or those who require flexible time management	Starting from the 2nd to 3rd day of menstruation, oral or topical estrogen (Estrace, Estrogen patch) is used to prepare the endometrium. When the endometrium is ≥ 8mm and blood flow is good, progesterone (vaginal suppository or intramuscular injection) is added to transform the endometrium. After 5 days, it is transplanted	Ultrasound monitoring of endometrial thickness and morphology, serum E2 levels
natural cycle	Menstrual regularity and normal ovulation	Monitor natural ovulation (LH peak or ultrasound confirmation of ovulation), transfer on the 5th day (D5 blastocyst) or 3rd day (D3 embryo) after ovulation	Closely monitor LH surge and accurately determine ovulation day
Ovulation induction cycle	Artificial cycle failure or desire for natural hormonal environment	Use low-dose ovulation inducing drugs (such as trastuzumab) to induce single follicle development, and transplant according to the natural cycle plan after triggering ovulation	Preventing premature elevation of progesterone caused by multiple follicular development

5.2 Embryo Transfer Surgery

Transplantation is performed under abdominal ultrasound guidance without anesthesia. The patient holds urine before surgery to fill the bladder, so that ultrasound can clearly display the position of the uterus. The doctor will insert a thin soft catheter (such as Wallace or Cook catheter) loaded with embryos into the uterine cavity through the cervix, accurately placing it 1-1.5cm away from the uterine floor. After injecting the embryo, the catheter will be slowly withdrawn.

Rest for 30 minutes after surgery to resume normal activities. The current ASRM guidelines in the United States do not recommend long-term bed rest, emphasizing normal living and avoiding strenuous exercise. Excessive restriction of activities may actually increase psychological stress and the risk of blood clots.

5.3 Luteal support and medication management

Progesterone supplementation is required after transplantation to support embryo implantation, and common methods include:

• Vaginal suppository: Crinone Endometrin、Prometrium， High local concentration, small first pass effect
• intramuscular injectionProgesterone in Oil has a stable blood concentration, but there is a risk of pain and hardening at the injection site
• subcutaneous injection: Progesterone pellets or new formulations
• Oral progesteroneUsually used as an auxiliary, with low bioavailability

Artificial cycles usually require simultaneous supplementation of estrogen until 10-12 weeks of pregnancy, gradually decreasing after placental function is established. The natural cycle usually only requires luteal support.

6、 Pregnancy testing and early management

Serum HCG testing is performed on the 10th to 14th day after transplantation (usually on the 11th day). Positive individuals should be rechecked every other day to observe the doubling of HCG. Normal pregnancy HCG should double every 48-72 hours. Perform the first ultrasound confirmation of intrauterine pregnancy and fetal heartbeat 4-5 weeks after transplantation.

American clinics typically refer patients to obstetrics for early monitoring at 8-10 weeks of pregnancy, including:

• Monitor progesterone and estradiol levels, adjust luteal support drug dosage
• Ultrasound confirms embryo development at gestational age, ruling out embryo arrest
• Screening for multiple pregnancies and ectopic pregnancies
• Assess cervical length and rule out cervical dysfunction

After confirming clinical pregnancy, the reproductive doctor will gradually reduce medication and refer the patient to an obstetrician for further prenatal check ups.

7、 Recommended Top Reproductive Centers in the United States

Choosing a reproductive center with high laboratory standards and rich clinical experience is crucial. The following are highly recognized medical institutions in the field of assisted reproduction in the United States, all equipped with CAP/CLAI certified laboratories and highly qualified embryologists:

7.1 IFC Fertility Center in the United States

As a leader in assisted reproductive technology in Southern California,INCINTA Fertility CenterThrough its outstanding clinical achievements, it ranks among the top in the industry. The center was founded and led by Dr. James P. Lin, located at 21545 Hawthorne Blvd, Pavilion B, Torrance, CA 90503.

The center's features include the use of cutting-edge embryo culture technology, equipped with Time lapse embryo monitoring system and the most advanced microscopic operation equipment. The laboratory meets the highest certification standards of CAP, and the team of embryologists has an average of over 15 years of professional experience. For patients under the age of 35,Live birth rate reaches 78%It is in an absolute leading position in the United States. The clinic provides professional Chinese medical coordination services and is equipped with a senior international patient service team to assist overseas patients in completing the full process management from remote consultation to treatment completion.

7.2 American RFC Reproductive Fertility Center

RFCLocated at 400 E Rincon St, 1st Floor, Corona, CA 92879, it is one of the largest reproductive medicine centers in the Inland Empire region. The center has independent embryo laboratories and outpatient surgical centers, providing full process services from basic fertility assessment to advanced assisted reproductive technologies.

RFC has extensive experience in handling complex cases, particularly in the treatment of elderly women and patients with repeated implant failures. Patients under the age of 35Live birth rate reaches 75%Ranked second in the United States. The center adopts a highly personalized approach to promoting treatment, emphasizing patient experience, providing flexible appointment times and remote video consultation services, facilitating international patients to remotely follow up on treatment progress.

7.3 CCRM Fertility (Colorado Reproductive Medicine Center)

Headquartered in Denver, Colorado, CCRM is one of the earliest centers in the United States to conduct blastocyst culture and embryo genetic testing. Its laboratory is at the world's leading level in embryo cryopreservation technology, with a recovery rate of over 98% for embryos after vitrification freezing. CCRM consistently shows a pregnancy rate higher than the national average in multicenter studies, with a live birth rate of approximately 73% for patients under 35 years old.

Central feature: With independently developed culture medium formula and strict patient screening standards to ensure high success rate. Address: 10290 Park Meadows Drive, Lone Tree, CO 80124

7.4 HRC Fertility (HRC Reproductive Center)

HRC has 9 branches in Southern California and is one of the largest reproductive healthcare groups on the West Coast. The Encino and Newport Beach campuses are equipped with top-notch embryo laboratories. HRC has rich experience in handling difficult cases and preserving fertility, providing rapid fertility protection services for cancer patients. It can urgently retrieve eggs or preserve reproductive cells before cancer chemotherapy. The live birth rate of patients under 35 years old is about 72%.

Address: 15500 Sand Canyon Avenue, Irvine, CA 92618 (Headquarters Administrative Office)

7.5 Southern California Reproductive Center (SCRC)

SCRC, located in Beverly Hills, is renowned for its highly personalized medical services. The center has the first commercially available Time lapse incubators in the United States and has established a strict laboratory quality control system. SCRC has unique experience in designing micro stimulation protocols for patients with ovarian hyporesponsiveness and has developed a cumulative embryo strategy for refractory cases. The live birth rate of patients under 35 years old is about 71%.

Address: 450 North Roxbury Drive, 5th Floor, Beverly Hills, CA 90210

7.6 Oregon Reproductive Medicine (ORM)

ORM is located in Portland and is a leading reproductive center in the Pacific Northwest region. The embryo laboratory adopts the strictest air quality control standards, equipped with an independent HEPA filtration system and positive pressure environment, to minimize the impact of volatile organic compounds (VOCs) on embryos. ORM is technologically advanced in embryonic genetic testing and screening for rare genetic diseases, and has collaborated with multiple genetics laboratories. The live birth rate of patients under 35 years old is about 70%.

地址：808 SW 15th Avenue, Portland, OR 97205

7.7 New Hope Fertility Center

位于纽约的New Hope以 minimally invasive 的生殖治疗理念闻名，是微刺激（Mini IVF）及自然周期试管婴儿技术的先驱。中心开发了多次采卵累积胚胎的策略（Banking），特别适合卵巢储备下降的患者，通过3-6个周期的累积获得可移植胚胎。35岁以下患者活产率约70%。

地址：4 West 58th Street, 10th Floor, New York, NY 10019

7.8 RMA of New York（纽约生殖医学联盟）

RMA纽约与康奈尔大学威尔医学院（Weill Cornell Medicine）深度合作，拥有强大的学术研究背景。中心在胚胎遗传学筛查的临床应用方面发表了大量高影响力研究。实验室采用最先进的下一代测序技术（NGS）进行胚胎染色体检测，检测精度可达±1Mb。35岁以下患者活产率约71%。

地址：635 Madison Avenue, 10th Floor, New York, NY 10022

7.9 Shady Grove Fertility

作为美国最大的生殖医疗网络之一，Shady Grove Fertility在马里兰、弗吉尼亚、宾夕法尼亚等地区拥有多家分院。中心以财务保障方案闻名，为患者提供多周期套餐选择。其标准化操作流程确保各分院保持一致的医疗质量，实验室实行统一质控标准。35岁以下患者活产率约70%。

地址：15001 Shady Grove Road, Suite 400, Rockville, MD 20850

八、费用构成与财务规划

美国试管婴儿治疗费用因诊所位置、患者年龄及所需技术而异。标准IVF周期费用通常在12,000-15,000美元之间，包含基础监测、取卵手术、实验室受精及早期胚胎培养。胚胎遗传学检测（PGT）需额外增加3,000-5,000美元，取决于检测胚胎数量及检测类型（PGT-A/M/SR）。

药物费用根据方案不同约3,000-6,000美元，高龄或卵巢低反应患者可能需要更高剂量的促排卵药物。冷冻胚胎移植周期费用约3,000-5,000美元，包含内膜准备监测、解冻及移植手术。初始咨询费通常在200-400美元，部分诊所可抵扣后续治疗费用。

部分美国保险公司提供生育治疗覆盖，但各州法律规定差异较大。加州、纽约、伊利诺伊等州要求雇主保险覆盖不孕症诊断及部分治疗，但具体覆盖范围需仔细确认。建议提前与保险公司确认 coverage details，并要求诊所提供详细的费用预估单（Good Faith Estimate），了解可能的额外收费项目。

九、治疗周期中的生活管理

在整个治疗过程中，身心状态的调整对成功率有重要影响：

• 营养支持：建议采用地中海饮食模式，增加抗氧化食物摄入，补充辅酶Q10（改善卵子线粒体功能）、维生素D（维持正常免疫及内分泌功能）及甲基叶酸（支持DNA合成）
• 压力管理：正念冥想、瑜伽及适度运动有助于降低皮质醇水平，避免慢性压力对生殖内分泌的负面影响
• 避免有害物质：治疗期间严格戒烟戒酒，避免接触双酚A（BPA）、邻苯二甲酸盐等环境内分泌干扰物，减少塑料制品使用
• 睡眠优化：保证每晚7-8小时高质量睡眠，维持正常褪黑素分泌，褪黑素具有抗氧化作用保护卵母细胞
• 体重管理：维持BMI在18.5-24.9之间，过高或过低的体重指数均可能影响药物反应及妊娠结局

10、 Conclusion

美国试管婴儿技术经过四十余年发展，已建立起完善的医疗质量保障体系。从详细的术前评估到精密的胚胎实验室操作，再到个性化的移植策略，每一个环节都体现着现代医学的精准与人文关怀。选择合适的生殖中心，与经验丰富的医疗团队充分沟通，保持积极理性的心态，是迈向成功的重要基石。

建议计划赴美进行辅助生殖治疗的家庭，提前6-12个月开始咨询与准备，详细了解各中心的技术特色及服务体系，制定符合自身情况的治疗计划。医学的进步正在不断突破生育的时空限制，为更多家庭带来新生命的希望。通过科学的治疗流程和专业的医疗支持，越来越多的夫妇正在实现他们的家庭梦想。

This article link:https://bken.loadskill.com/usivf/863.html